CareMax (CMAX) Tops Q4 EPS by 2c

CareMax (NASDAQ: CMAX) reported Q4 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $118.3 million versus the consensus estimate of $118.44 million.

GUIDANCE:

CareMax sees FY2022 revenue of $540-560 million, versus the consensus of $590.5 million.

For earnings history and earnings-related data on CareMax (CMAX) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Securitize Corp (SECZ) PT Lowered to $10 at Benchmark as Stock Plummets Post Q2 Earnings
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30